Marksans Pharma Limited has informed the Exchange regarding a press release dated January 11, 2022, titled "Marksans Pharma Limited announces final approval for Cetirizine Hydrochloride Tablets 5 mg and 10mg from US FDA.".
Marksans Pharma Limited has informed the Exchange regarding a press release dated January 11, 2022, titled "Marksans Pharma Limited announces final approval for Cetirizine Hydrochloride Tablets 5 mg and 10mg from US FDA.".